Cormorant Asset Management, LP Pliant Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

  • $1.43 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$18.73 - $36.26 $12.4 Million - $24 Million
661,212 Added 84.47%
1,444,000 $38.4 Million
Q3 2022

Nov 14, 2022
BUY
$7.67 - $24.23 $2.3 Million - $7.28 Million
300,375 Added 62.27%
782,788 $16.4 Million
Q2 2021

Aug 16, 2021
SELL
$28.05 - $37.69 $3.62 Million - $4.86 Million
-128,996 Reduced 21.1%
482,413 $14 Million
Q2 2020

Aug 14, 2020
BUY
$21.3 - $35.26 $13 Million - $21.6 Million
611,409 New
611,409 $18.8 Million

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email